The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
The mission of BrainNow is to develop and commercialize clinically applicable computer-aided (CAD) software tools for diagnosis of dementia and other neurodegenerative diseases. Our product meets the requirements for accurate extraction of the relevant biomarkers, and enables their efficient use in clinical practice and clinical research, by providing a comprehensive visualization and analysis workflow that are related to values derived from large population-based imaging studies.
The major functionality of our product is
1) to support early detection of potential dementia from normal ageing-related cognitive decline;
2) to support differential diagnosis to classify different types of dementia.